These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7797948

  • 21. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
    Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, Möst J.
    Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
    [Abstract] [Full Text] [Related]

  • 22. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts.
    Phillips AN, Sabin CA, Elford J, Bofill M, Janossy G, Lee CA.
    Am J Epidemiol; 1993 Nov 15; 138(10):870-8. PubMed ID: 7901990
    [Abstract] [Full Text] [Related]

  • 23. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
    Woffendin C, Ranga U, Yang Z, Xu L, Nabel GJ.
    Proc Natl Acad Sci U S A; 1996 Apr 02; 93(7):2889-94. PubMed ID: 8610137
    [Abstract] [Full Text] [Related]

  • 24. Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.
    Koot M, van Leeuwen R, de Goede RE, Keet IP, Danner S, Eeftinck Schattenkerk JK, Reiss P, Tersmette M, Lange JM, Schuitemaker H.
    J Infect Dis; 1999 Jan 02; 179(1):254-8. PubMed ID: 9841850
    [Abstract] [Full Text] [Related]

  • 25. The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam.
    Bindels PJ, Krol A, Roos M, Veenstra J, van den Hoek JA, Miedema F, Coutinho RA.
    J Infect Dis; 1995 Jul 02; 172(1):97-104. PubMed ID: 7797949
    [Abstract] [Full Text] [Related]

  • 26. Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion.
    Begtrup K, Melbye M, Biggar RJ, Goedert JJ, Knudsen K, Andersen PK.
    Am J Epidemiol; 1997 Apr 01; 145(7):629-35. PubMed ID: 9098180
    [Abstract] [Full Text] [Related]

  • 27. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study.
    Saah AJ, Muñoz A, Kuo V, Fox R, Kaslow RA, Phair JP, Rinaldo CR, Detels R, Polk BF.
    Am J Epidemiol; 1992 May 15; 135(10):1147-55. PubMed ID: 1352940
    [Abstract] [Full Text] [Related]

  • 28. In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.
    Maas JJ, Roos MT, Keet IP, Mensen EA, Krol A, Veenstra J, Schellekens PT, Jurriaans S, Coutinho RA, Miedema F.
    J Infect Dis; 1998 Oct 15; 178(4):1024-9. PubMed ID: 9806030
    [Abstract] [Full Text] [Related]

  • 29. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.
    Mandalakas AM, Guay L, Musoke P, Carroll-Pankhurst C, Olness KN.
    Pediatrics; 1999 Feb 15; 103(2):E21. PubMed ID: 9925867
    [Abstract] [Full Text] [Related]

  • 30. Calculation and use of an HIV-1 disease progression score.
    Roussanov BV, Taylor JM, Giorgi JV.
    AIDS; 2000 Dec 01; 14(17):2715-22. PubMed ID: 11125890
    [Abstract] [Full Text] [Related]

  • 31. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG, Sirivichayakul S, Phillips AN, Ubolyam S, Ruxrungtham K, Hanvanich M, Phanuphak P.
    Int J Epidemiol; 1998 Apr 01; 27(2):289-95. PubMed ID: 9602412
    [Abstract] [Full Text] [Related]

  • 32. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA, Obregón E, Navarro J, Börner C, Gurbindo MD, Sampelayo TH, Fernández-Cruz E.
    Pediatr Res; 1996 Oct 01; 40(4):597-602. PubMed ID: 8888289
    [Abstract] [Full Text] [Related]

  • 33. Natural history of HIV-1 cell-free viremia.
    Henrard DR, Phillips JF, Muenz LR, Blattner WA, Wiesner D, Eyster ME, Goedert JJ.
    JAMA; 1995 Aug 16; 274(7):554-8. PubMed ID: 7629984
    [Abstract] [Full Text] [Related]

  • 34. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons.
    Blatt SP, McCarthy WF, Bucko-Krasnicka B, Melcher GP, Boswell RN, Dolan J, Freeman TM, Rusnak JM, Hensley RE, Ward WW.
    J Infect Dis; 1995 Apr 16; 171(4):837-44. PubMed ID: 7535828
    [Abstract] [Full Text] [Related]

  • 35. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
    Hulgan T, Raffanti S, Kheshti A, Blackwell RB, Rebeiro PF, Barkanic G, Ritz B, Sterling TR.
    J Infect Dis; 2005 Sep 15; 192(6):950-7. PubMed ID: 16107946
    [Abstract] [Full Text] [Related]

  • 36. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.
    J Infect Dis; 2006 Jul 01; 194(1):29-37. PubMed ID: 16741879
    [Abstract] [Full Text] [Related]

  • 37. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population.
    Roman M, Rodriguez JW, Pagán NO, Rios-Olivares E, Amill A, Hunter R.
    P R Health Sci J; 2002 Sep 01; 21(3):195-201. PubMed ID: 12243109
    [Abstract] [Full Text] [Related]

  • 38. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D.
    Arch Intern Med; 1995 Oct 23; 155(19):2111-7. PubMed ID: 7575072
    [Abstract] [Full Text] [Related]

  • 39. Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.
    Sitz KV, Loomis-Price LD, Ratto-Kim S, Kenner JR, Sau P, Eckels KH, Redfield RR, Birx DL.
    J Infect Dis; 1997 Oct 23; 176(4):1085-9. PubMed ID: 9333173
    [Abstract] [Full Text] [Related]

  • 40. [AIDS in Denmark. 2. Survival after the diagnosis of AIDS. Danish Study Group for HIV infection].
    Lundgren JD, Pedersen C, Bentsen KD, Gerstoft J, Seefeldt-Nielsen T, Nielsen TL, Jensen GF.
    Ugeskr Laeger; 1995 Mar 06; 157(10):1352-6. PubMed ID: 7709483
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.